 |
南京科佰生物科技有限公司
主營產(chǎn)品： atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買 |
員.png)
10
聯(lián)系電話
|
南京科佰生物科技有限公司
主營產(chǎn)品： atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買 |
聯(lián)系電話
| 參考價(jià) | 面議 |
更新時(shí)間：2022-08-03 10:35:22瀏覽次數(shù)：565
聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息，謝謝!
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | T-25 Flask |
|---|---|---|---|
| 貨號 | CBP73278 | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
| 主要用途 | 僅限科研使用 |
| CBP73278 | |
| I. Introduction | |
Cell Line Name： | BCR-ABL1 [Q252H/T315I] /BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, plays a role in regulation of cell growth through ERK5, Rac/JNK, and Stat1/3 pathways (PMID: 10373409). Fusion proteins of BCR-ABL1 resulting in constitutive kinase activity have been reported in various cancers (PMID: 18851712, PMID: 30125955) and a number of Abl1 mutations in the context of BCR-ABL1 have been demonstrated to confer drug resistance (PMID: 24456693). | |
| III. Representative Data | |
1.WB of BCR-ABL1 [Q252H/T315I] /BaF3
| |
2. Sanger of BCR-ABL1 [Q252H/T315I] /BaF3
Figure 2. BCR-ABL1 [Q252H/T315I] /BaF3 Fusion
Figure 3. BCR-ABL1 [Q252H/T315I] /BaF3 Q252H Mutation
Figure 4. BCR-ABL1 [Q252H/T315I] /BaF3 T315I Mutation | |
3. Anti-proliferation assay
Figure 5 .CTG Proliferation Assay of BaF3 BCR-ABL1 T315I Q252H Cells (C1). | |
